The Biostatistics Core (Biostats) is a centralized and dedicated resource structured to meet biostatistical needs of the Holden Comprehensive Cancer Center (HCCC). Quality biostatistical support promotes good study design, efficient use of resources, and effective analysis of data. Biostats provides such support in close collaborations with HCCC members, other shared research resources, and administration to advance the research and education missions of the HCCC. The comprehensive nature of Biostats assures cost-effective access to biostatistical support that includes study design and development; protocol review and study monitoring; research data management; statistical analysis and programming; analysis reporting and publication; methodological development; and education, training, and professional development. The primary resources of Biostats are the expertise and time of its biostatistician personnel. In order to meet HCCC biostatistical needs, Biostats includes personnel who have a wide range of expertise, including experimental design, clinical trials, statistical computing, spatially and temporally correlated data analysis, genetic and genomic data analysis, and Bayesian statistics. Personnel are active participants in multiple aspects of the HCCC. They serve on the HCCC Protocol Review and Monitoring Committee and the Data Safety and Monitoring Committee. In the current grant period, they collaborated with 73 HCCC investigators on 269 research projects, including 37 investigator-initiated clinical trials. Collaborations involved all research programs and close interactions with the Bioinformatics Shared Resource, Population Research Core, and Molecular Epidemiologic Resource, as well as the Clinical Research Support Office. Additionally, Biostats provided educational training and professional development. It advised 31 trainees on biostatistical methods and results related to supported projects, gave seminars, and conducted a biostatistics course for trainees. In summary, Biostats is a highly collaborative, productive, and integrated resource that is vital for the HCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-18
Application #
9460394
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
18
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Chiba, Akiko; Raman, Rachna; Thomas, Alexandra et al. (2018) Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. Clin Breast Cancer 18:144-149
Vikas, Praveen; Borcherding, Nicholas; Zhang, Weizhou (2018) The clinical promise of immunotherapy in triple-negative breast cancer. Cancer Manag Res 10:6823-6833
Alexander, Matthew S; Cullen, Joseph J (2018) Treating pancreatic cancer: more antioxidants more problems? Expert Rev Gastroenterol Hepatol 12:849-851
Lin, Jie; Adjeroh, Donald A; Jiang, Bing-Hua et al. (2018) K2 and K2*: efficient alignment-free sequence similarity measurement based on Kendall statistics. Bioinformatics 34:1682-1689
Koppenhafer, Stacia L; Goss, Kelli L; Terry, William W et al. (2018) mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells. Mol Cancer Ther 17:2676-2688
Lutgendorf, Susan K; Thaker, Premal H; Arevalo, Jesusa M et al. (2018) Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma. Cancer 124:580-586
Krishnamani, Venkatramanan; Peterson, Tabitha A; Piper, Robert C et al. (2018) Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens. J Vis Exp :
Al-Qurayshi, Zaid; Khadra, Helmi; Chang, Kristi et al. (2018) Risk and survival of patients with medullary thyroid cancer: National perspective. Oral Oncol 83:59-63
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Campbell, Hannah; Heidema, Christy; Pilarczyk, Daisy G et al. (2018) SHP-2 is activated in response to force on E-cadherin and dephosphorylates vinculin Y822. J Cell Sci 131:

Showing the most recent 10 out of 1080 publications